No Subgroup More Likely to Benefit From to Meniscal Surgery
A statistical analysis failed to identify any group of patients who are especially likely to benefit from arthroscopic partial meniscectomy.
Related Articles
#DiedSuddenly Was BS: Why Did We Believe It?
A hashtag that gained a lot of traction during the COVID-19 pandemic is, thankfully, in decline, but can we avoid buying into such nonsense again?
Managing Familial Hypercholesterolemia in Primary Care
Familial hypercholesterolemia is often diagnosed late, and patients with the condition are significantly undertreated.
Increasing, Persistent PSA Levels Linked to Higher All-Cause Mortality
Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause mortality risk.
FLAGging Down Updates in Cutaneous Melanoma: Investigating the Role of LAG-3
Join this dynamic expert dialogue about the latest data on lymphocyte activating gene 3 (LAG-3) inhibitors in advanced cutaneous melanoma.
Epicutaneous Immunotherapy: The Future of Peanut Allergy Treatment?
Longer term use of a skin patch helps treat peanut allergies in some children, a new study finds.
AML: Monitor Early Measurable Residual Disease to Optimize Outcomes
Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.
A Woman With Atraumatic Wrist Pain
The patient’s past medical history is notable only for hypothyroidism.
Polypharmacy in Psychiatry: Good, Bad, or Just Unavoidable?
Studies suggest psychotropic polypharmacy may be on the rise. But experts say whether that’s good or bad — or even unavoidable — is more nuanced.
Dermatomyositis Misdiagnosis Common, Affects Outcomes
A retrospective study highlights the high misdiagnosis rates of dermatomyositis, particularly its amyopathic subtype, and the associated increase in hospitalizations and worse lung function.
Hallucinogens May Elevate Death Risk by More Than Twofold
Future research will show whether the change in the availability of hallucinogens affects the risks associated with these drugs.